Vorolazan Intermediate 5 - (2-fluorophenyl) - 1 - [- YL) Sulfonyl] - 1H-pyrrol-3-formatdehyde Cas. 881677-11-8

Vorolazan Intermediate yog ib qho tseem ceeb hauv cov hluavtaws ntawm Vorolazan, kev sib tw potidassium-solteritive acid blocker siv cov kab mob uas muaj feem xyuam. Qhov kev sib txuas nruab nrab no yog qhov tseem ceeb ntawm kev tsim cov Vorolazan thiab tseem ceeb heev rau kev lag luam kws tshuaj.

Vorolazan Intermediates muaj cov qauv tshuaj lom neeg thiab cov qauv tshuaj lom neeg, ua rau lawv haum rau R & D thiab loj-teev ntau lawm. Peb cov khoom lag luam nruj kev ntsuas kev tswj hwm kom ntseeg tau tias lawv li kev sib xws thiab ntseeg tau, ua kom zoo tshaj plaws rau cov chaw tsim tshuaj thiab cov kws tshawb nrhiav.

Cov compound no tau muaj txiaj ntsig zoo nyob rau hauv lub luag haujlwm ntawm cov kws tshuaj paus kev lag luam nyob rau hauv cov synthesis ntawm vorolazan, tshuaj tawg rau kev kho cov kua txob. Raws li Vorolazan tseem nce qhov kev lees paub rau nws cov txiaj ntsig hauv kev tswj hwm ntawm cov pa roj carbon degruesophageal reflux tus kab mob thiab cuam tshuam rau vorolazan intermediates yog nce.